Ranitidine and somatostatin. Their effects on bleeding from the upper gastrointestinal tract.

In a randomized, double-blind placebo-controlled clinical trial, the effect of ranitidine was compared with the effect of somatostatin in the control of massive gastrointestinal tract bleeding. Ninety-six patients completed the study. Rates of continuing bleeding and death, incidence of surgery, and blood transfusion requirements were not significantly different in the three treatment groups. Eighteen of the 96 patients presented with a visible vessel at endoscopy. In this group the percent of patients with continuing bleeding, mean transfusion requirements, and mortality were significantly higher than in patients without a visible vessel. Seven patients with a visible vessel underwent surgery and six survived; 11 patients underwent conservative measures and eight died. Ranitidine and somatostatin do not seem to alter the clinical course of patients with upper gastrointestinal tract hemorrhage.

[1]  K. Hine,et al.  SOMATOSTATIN IN TREATMENT OF HAEMATEMESIS AND MELAENA , 1985, The Lancet.

[2]  S. Lombardi,et al.  Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract. , 1984, British medical journal.

[3]  S. Ellis,et al.  Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. , 1983, The New England journal of medicine.

[4]  R. Cockel,et al.  Ranitidine in acute upper gastrointestinal haemorrhage , 1982, British medical journal.

[5]  T. Northfield,et al.  Endoscopic prediction of recurrent bleeding in peptic ulcers. , 1981, The New England journal of medicine.

[6]  B. Limberg,et al.  SOMATOSTATIN FOR CIMETIDINE-RESISTANT GASTRODUODENAL HÆMORRHAGE , 1980, The Lancet.

[7]  M. Wall,et al.  SOMATOSTATIN AND CIMETIDINE IN PEPTIC-ULCER HÆMORRHAGE A Randomised Controlled Trial , 1980, The Lancet.

[8]  S. Bülow,et al.  Cimetidine for severe gastroduodenal haemorrhage: a randomized controlled trial. , 1980, Scandinavian journal of gastroenterology.

[9]  R. Udén,et al.  Effect of somatostatin on regional splanchnic blood flows in man. Angiographic studies. , 1980, Acta chirurgica Scandinavica. Supplementum.

[10]  J. Misiewicz,et al.  Controlled trial of cimetidine in upper gastrointestinal haemorrhage. , 1979, Gut.

[11]  W. J. Griffiths,et al.  The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal hemorrhage. , 1979, The New England journal of medicine.

[12]  M. South,et al.  Controlled trial of cimetidine in acute upper gastrointestinal bleeding. , 1979, British medical journal.

[13]  G. Eastwood.  Does early endoscopy benefit the patient with active upper gastrointestinal bleeding? , 1977, Gastroenterology.

[14]  P. Dykes,et al.  A study of the factors influencing mortality rates from gastrointestinal haemorrhage. , 1976, The Quarterly journal of medicine.

[15]  S. Truelove,et al.  Haematemesis and Melaena, with Special Reference to Factors Influencing the Outcome , 1970, British medical journal.

[16]  C. Clark,et al.  A method for the rapid determination of the number of patients to include in a controlled clinical trial. , 1966, Lancet.